Findings reveal associations between COX-2 polymorphisms and migraine features, suggesting further research is needed.
Our findings provide preliminary evidence that COX-2 gene polymorphisms, particularly the 1195 A > G variant, may be associated with migraine clinical features, such as onset and severity. However, given limited subgroup sizes, these associations should be interpreted with caution. Further investigation in larger, independent cohorts is warranted to validate these results and clarify the role of the COX-2 pathway in migraine pathophysiology.
No takes yet. Share an insight, caveat, or question.
Mozaffari et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: